Close
Nordic 9Nordic 9

MP Healthcare Venture Management (investor - Corporate Investor)

United States mp-healthcare.com
See something wrong or missing? Let us know
Offices:Boston

MPH is the venture capital arm of Mitsubishi Tanabe Pharma Corp

Average round investment:45.43M USD
Average number per year:1.3
Distribution: 2025 (2)2024 (1)2023 (1)
Portfolio companies: Switzerland GlycoEraUnited Kingdom Trimtech TherapeuticsDenmark Draupnir Bio See the entire list
Mostly invests in: United Kingdom United Kingdom (2) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to MP Healthcare Venture Management

Name Criteria
Germany Roman Schumacher
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Aidan Gomez
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany RV Invest
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States DRW Venture Capital
92%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Green Sands Equity
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Top Harvest Capital
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Pharma, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
United Kingdom Francesca Baillieu
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Netherlands Rabo Frontier Ventures
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 1.9
  • Active last 12 months: Yes
United States Day One Ventures
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Sweden Niklas Zennström
91%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Biotech, Competitive Intelligence
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Top